Atropine Sulfate: Clinical Trials

27 trials of Atropine Sulfate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 2 recruiting, 2 unknown, 2 withdrawn. 8 Phase 2, 7 Phase 1, 4 Not applicable, 4 Phase 3, 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Completed 6, Active not recruiting 1, Unknown 1
Phase 17Completed 5, Unknown 1, Withdrawn 1
Not applicable4Completed 4
Phase 34Completed 4
Early Phase 13Recruiting 2, Withdrawn 1
Phase 43Completed 3

Follow Atropine Sulfate: new trials by email Literature Review of Atropine Sulfate trials Research Report on Atropine Sulfate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation.
Dexmedetomidine infusion, Dexmedetomidine bolus, Atropine Sulfate - Dexmedetomidine, Intubation Complication
Phase 2CompletedKasr El Aini Hospital702024-04-012026-07-09
Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children
Atropine Sulfate, Placebo - Myopia
Phase 3CompletedOcumension Therapeutics (Suzhou) Co., Ltd1482023-06-252024-11-20
A Study of Atropine Sulfate in Healthy Chinese Volunteers
Atropine sulfate eye drops - Pharmacokinetics
Phase 1UnknownZhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited302023-05-092023-05-11
Safety and Tolerability Evaluation of PRO-230 Ophthalmic Solution
Atropine Sulfate - Myopia
Phase 1WithdrawnLaboratorios Sophia S.A de C.V.2023-02-012024-07-01
Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201
Atropine Sulfate - Myopia
Phase 1CompletedLaboratorios Sophia S.A de C.V.292022-08-202026-02-05
Dropless Pars Plana Vitrectomy Study
Pars plana vitrectomy, Triamcinolone Acetonide 40mg/mL, Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin - Rhegmatogenous Retinal Detachment
Phase 4CompletedMassachusetts Eye and Ear Infirmary1682022-07-252026-09-18
Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop
CBT-009, Vehicle, Atropine Sulfate - Myopia, Progressive
Phase 1 / Phase 2CompletedCloudbreak Therapeutics, LLC842022-07-202023-01-27
The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia
Safflower (Carthamus Tinctorius) IgG4 | Serum | Allergy, Atropine Sulfate - Hypertensive Heart Disease
Not applicableCompletedJun Xiao722020-01-202020-08-10
Intrathecal Atropine vs IV Metoclopramide for Nausea & Vomiting During CS
Atropine sulfate, Metoclopramide - Nausea, Vomiting
Phase 4CompletedMansoura University602019-05-052019-10-07
The Safety and Efficacy of SYD-101 in Children With Myopia
SYD-101 0.01%, SYD-101 0.03%, Vehicle - Nearsightedness, Near Sightedness
Phase 3CompletedSydnexis, Inc.8522019-04-242026-07-30
Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training
Handgrip Exercise Training, Acetylcholine, Adenosine Triphosphate - Vasoconstriction, Vasodilation
Early Phase 1WithdrawnColorado State University2019-04-162021-08-02
Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom
Atropine Sulfate, Placebo - Myopia
Phase 2Active not recruitingBelfast Health and Social Care Trust2892019-04-032023-09-07
Side Effects of Atropine (SEA) Study
0.01% concentration atropine drops - Myopia
Phase 1 / Phase 2CompletedJeffrey J. Walline, OD PhD312018-07-232022-12-02
Adverse Events Related to Low Dose Atropine
Atropine Sulfate - Myopia, Progressive
CompletedScripps Health1482018-06-192023-04-25
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
E7 TCR cells, Aldesleukin, Fludarabine - Papillomavirus Infections, Cervical Intraepithelial Neoplasia
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)2242017-01-272026-03-09
The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)
Lidocaine, Sevoflurane, TIVA-TCI - Breast Cancer
Phase 2CompletedIuliu Hatieganu University of Medicine and Pharmacy1202016-08-012019-10-29
The Effects of Bariatric Surgeries on Glucose Metabolism
Exendin-(9-39), Atropine - Post Bariatric Surgery, Gastric Bypass
Early Phase 1RecruitingThe University of Texas Health Science Center at San Antonio2002015-07-012025-09-09
StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study
PSE 120 mg, CM 8 mg, Atr 0.36 mg, PSE 120 mg, CM 8 mg, Atr 0.24 mg, PSE 120 mg, CM 8 mg, Atr 0.12 mg - Rhinitis, Seasonal, Allergic
Phase 2UnknownMagna Pharmaceuticals, Inc.1252014-03-012014-05-30
Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants
Atropine - Bradycardia, Arrhythmias
Phase 4CompletedState University of New York at Buffalo602013-02-012023-04-06
Intubation Time With Low Dose Rocuronium
Atropine, Normal saline - Intubation; Difficult
Not applicableCompletedGachon University Gil Medical Center442011-05-012011-11-03

Showing 20 of 27. Sign in to see all of them.

Conditions studied

Myopia (7)  ·  Hypoglycemia (2)  ·  Myopia, Degenerative (2)  ·  Aneurysm (1)  ·  Arrhythmias, Cardiac (1)  ·  Bradycardia (1)  ·  Breast Neoplasms (1)  ·  Carcinoma in Situ (1)  ·  Heart Arrest (1)  ·  Inflammation (1)  ·  Motor Activity (1)  ·  Nausea (1)  ·  Organophosphate Poisoning (1)  ·  Papillomavirus Infections (1)  ·  Photophobia (1)

Sponsors

Laboratorios Sophia S.A de C.V. (2)  ·  The University of Texas Health Science Center at San Antonio (2)  ·  Baskent University (1)  ·  Belfast Health and Social Care Trust (1)  ·  Cloudbreak Therapeutics, LLC (1)  ·  Colorado State University (1)  ·  Craig J. Huang (1)  ·  Gachon University Gil Medical Center (1)  ·  Iuliu Hatieganu University of Medicine and Pharmacy (1)  ·  Jeffrey J. Walline, OD PhD (1)  ·  Jun Xiao (1)  ·  Kasr El Aini Hospital (1)  ·  Magna Pharmaceuticals, Inc. (1)  ·  Mansoura University (1)  ·  Massachusetts Eye and Ear Infirmary (1)

Countries

United States (13)  ·  China (3)  ·  Egypt (2)  ·  Australia (1)  ·  Austria (1)  ·  Mexico (1)  ·  Norway (1)  ·  Romania (1)  ·  Slovakia (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Marzieh Salehi, MD, MS (2)  ·  Adriana Rodriguez, MD (1)  ·  Anand Chockalingam, MD (1)  ·  Anis Aribogan, Prof., MD (1)  ·  Augusto Azuara-Blanco, PhD FRCOphth (1)  ·  Craig Huang, MD (1)  ·  Frank Dinenno, PhD (1)  ·  Gregory Ostrow, MD (1)  ·  Jeffrey Walline (1)  ·  Jerrold Lerman, MD FRCPC (1)  ·  Jong Yeop Kim, MD,PhD (1)  ·  Lars Wik, MD, PhD (1)  ·  Li Li (1)  ·  Michael Donahoe, M.D. (1)

Results publications

PMID 19934423, PMID 22698066, PMID 24247230, PMID 24465046, PMID 25762533, PMID 25794212, PMID 31653669, PMID 32616309, PMID 33558725, PMID 41870844, PMID 42276557

NIH funding

2017 (1), R01DK105379 (1)